NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
81279 Gene analysis (janus kinase 2) targeted sequence analysis CPT · Molecular Testing
Classification Test Molecular Testing Genetic Analysis (CMS RBCS)
First observed 2021
National scale 56,048 services ▲ 27.9% YoY · 55,588 beneficiaries (CY2024, Medicare FFS)
Medicare paid $10.1M · $180.52 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups
6
Named-group FFS services
2,583
FFS of Medicare
49%
Services YoY
+27.9%
FFS enrollment -2.2%
Estimated all-Medicare volume FFS + estimated MA estimate
~5,733 services

2,583 observed fee-for-service (45%) · ~3,150 estimated Medicare Advantage. Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale

Top states — 81279 (CY2024)

Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market.

Named-group submitted charges
$1.5M
Named-group allowed amount
$468K
Named-group Medicare payments
$468K
Avg charge / svc
$567
Avg allowed / svc
$181
Avg payment / svc
$181
Average charge per group
$406 6 groups · avg submitted charge / service $741
Market analyticsPlatform
a taste of the twelve-year trend layer

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →

Nevvi's market analytics platform — code baskets, market structure and share, the twelve-year trend layer — is built and not launched yet. We're gathering interest in it.

Notify me at launch →
Refine: practice size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by 81279 services, highest first, CY2024
# Physician group activate to sort City activate to sort St activate to sort Specialty activate to sort Providers activate to sort 81279 svcs sorted descending — activate to reverse Submitted charges activate to sort Avg charge activate to sort Medicare $ locked column Share* activate to sort Phone
1 FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC FORT MYERS FL HEMATOLOGY/ONCOLOGY 437 1,018 $490,676 $482 premium 3.5% (239) 561-9622
2 NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC SMITHTOWN NY NURSE PRACTITIONER 462 637 $472,017 $741 premium 89.1% (631) 751-3000
3 AMERICAN ONCOLOGY PARTNERS PA FORT WAYNE FL HEMATOLOGY/ONCOLOGY 333 617 $343,052 $556 premium 2.1% (260) 484-8830
4 INTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC ATLANTIS FL PATHOLOGY 133 151 $72,782 $482 premium 0.5% (561) 548-3639
5 CANCER SPECIALISTS LLC JACKSONVILLE FL HEMATOLOGY/ONCOLOGY 46 80 $32,452 $406 premium 0.3% (904) 516-3737
6 REGIONAL CANCER CARE ASSOCIATES LLC HACKENSACK NJ HEMATOLOGY/ONCOLOGY 153 51 $33,048 $648 premium 0.6% (201) 996-2210
7 NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC SMITHTOWN MO NURSE PRACTITIONER 462 29 $21,489 $741 premium 100.0% (631) 751-3000

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →